Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Talphera Inc TLPH

Healthcare
Talphera, Inc., formerly AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Niyad is focused on developing regional anticoagulants for injection into the extracorporeal circuit, such as the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:TLPH)

Talphera to Participate at A.G.P. Virtual Healthcare Conference

PR Newswire 1 day ago

Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update

PR Newswire 3 days ago

Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024

PR Newswire May 2, 2024

Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update

PR Newswire March 6, 2024

Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members

PR Newswire March 1, 2024

Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024

PR Newswire February 26, 2024

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

PR Newswire January 18, 2024

AcelRx Announces Rebranding With Name Change to Talphera, Inc.

PR Newswire January 9, 2024

AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States

PR Newswire December 12, 2023
View More News ››

Opinion & Analysis (NDAQ:TLPH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TLPH)

BEAR MARKET

I dont know what I would do without the help of BULLALERTS Their watchlists are so well researched and help me make the best possible...
wabomebuypo16 - November 2, 2022

FDA Vote On Friday

US Food and Drug Administration released briefing materials interpreted as a positive opinion on the company's DSUVIA pain reliever...
Dragotex - October 10, 2018

short city

if I could shares I would short this sucker for sure she is abou to POP> 
BlameOG - September 25, 2018

What's poignant ACRX into a Blazing Stock...

ACRX achieve a huge landmark today as an new high,$ACRX on 1440174 volume. I would have never estimated it but if you stare at the trends...
coffeyg - November 15, 2012
View more Bullboard ››

E-Power Resources Inc

E-Power Resources Inc

E-Power Resources Inc. is a Canada-based exploration stage company. The Company is engaged principally in the acquisition ...
View More »